Pharmaceutical sales and marketing news from FiercePharma
News
Merck to cut 1,200 sales reps
The axeman cometh to Merck's sales force. The drugmaker plans to lop off about 15 percent in the sales ranks, or 1,200 jobs. The fact that it's not alone in trimming back on reps--Wyeth just Read more...
J&J laying off 400 in marketing overhaul
With Procrit under siege, Johnson & Johnson wants to divert its promotional efforts elsewhere--a strategy that will lead to some 400 job cuts in its sales-and-marketing ranks. The company told Read more...
AAMC: Ban pharma gifts at med schools
Will all medical schools bar the door to pharma giveaways? The Association of American Medical Colleges hopes so. After two years of study, the influential group drafted a policy that would ban drug Read more...
Med schools tight with drug makers
You can't accuse pharma companies of failing to think ahead. They begin to forge links with future doctors before they even start med school. And according to a new study in the Journal of the Read more...
Analyst: Generics makers sitting pretty
Speaking of generic drug makers, here's a news flash: Their revenue will continue to soar in coming years, according to a top industry analyst from IMS Health. Global sales of generics already are Read more...
After controversy, Plan B sales strong
Like Madonna, the Plan B has faced its share of controversy. Like Hilary Clinton, it's attracted more than its share of political sniping. Like both, it's risen undeterred. Since Plan B was approved Read more...
IMS lists best drug launches of all time
It's not easy being a global pharmaceuticals company. First, you have to develop drugs--and then you have to sell them, not only to your home country, but around the world. And there lies the rub, Read more...
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight